IGC Pharma, Inc. (IGC)

NYSEAMERICAN: IGC · Real-Time Price · USD

0.3339

+0.0262 (8.51%)

At close: Aug 27, 2026, 4:00 PM EDT

0.3390

+0.0051 (1.53%)

Pre-market: Aug 28, 2026, 5:06 AM EDT

IGC Pharma Financials Overview

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	1.11	1.27	1.35	0.91	0.4	0.9
Revenue Growth	-6.51%	-5.50%	47.64%	129.47%	-55.79%	-77.95%
Gross Profit	0.51	0.62	0.73	0.44	0.19	0.11
Operating Income	-8.1	-7.45	-9.8	-11.57	-14.6	-8.72
Net Income	-6.45	-7.12	-13	-11.51	-15.02	-8.81
Earnings Per Share	-0.08	-0.09	-0.22	-0.22	-0.30	-0.21
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
United States of America	1.11	1.27	1.18	0.78	0.33	0.72
Colombia	-	0	0	0.02	-	-
India	-	-	0.16	0.11	0.07	0.18
Total	1.11	1.27	1.35	0.91	0.4	0.9

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Investments	1.13	0.41	1.2	3.35	10.46	14.63
Total Debt	0.15	0.24	0.35	0.48	0.61	1.08
Net Cash (Debt)	0.98	0.17	0.85	2.87	9.85	13.55
Net Cash Growth	-20.77%	-80.42%	-70.27%	-70.87%	-27.33%	15.69%
Net Cash Per Share	0.01	0.00	0.01	0.05	0.20	0.32

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Operating Cash Flow	-5.54	-4.8	-5.2	-7.05	-7.46	-10.8
Capital Expenditures	-0.08	-0.11	-0.14	-0.31	-0.24	-1.47
Free Cash Flow	-5.63	-4.91	-5.34	-7.36	-7.7	-12.27
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Gross Margin	46.20%	48.70%	54.50%	48.52%	48.87%	12.58%
Operating Margin	-731.92%	-585.84%	-728.48%	-1270.14%	-3676.32%	-971.49%
Pretax Margin	-582.82%	-560.27%	-966.54%	-1263.01%	-3782.37%	-981.18%
Profit Margin	-582.82%	-560.27%	-966.54%	-1263.01%	-3782.37%	-981.18%
FCF Margin	-508.68%	-386.07%	-396.80%	-807.57%	-1939.04%	-1366.37%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Forward PE	-	4.35	4.35	4.35	4.35	4.35
PS Ratio	31.21	17.87	19.65	19.78	122.03	90.43